logo

QNCX

Quince Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

QNCX fundamentals

Quince Therapeutics (QNCX) expects to report earnings on Aug 12, 2025, with estimated revenue of -- (YoY 0.00%), and EPS at -0.2 (YoY +68.75%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
-0.2
+68.75%
Report date
Aug 12, 2025
EPS
Revenue

Revenue & Expenses

Key Indicators

Quince Therapeutics (QNCX) key financial stats and ratios, covering profitability, financial health, and leverage.
Quince Therapeutics (QNCX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Quince Therapeutics (QNCX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Quince Therapeutics (QNCX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Quince Therapeutics (QNCX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Quince Therapeutics (QNCX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield